372 related articles for article (PubMed ID: 15791294)
1. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
[TBL] [Abstract][Full Text] [Related]
3. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
[TBL] [Abstract][Full Text] [Related]
6. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
Lambert AL; Trasti FS; Mangum JB; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365
[TBL] [Abstract][Full Text] [Related]
7. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.
Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
Cell Immunol; 2000 Nov; 206(1):1-6. PubMed ID: 11161432
[TBL] [Abstract][Full Text] [Related]
8. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally.
Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M
J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825
[TBL] [Abstract][Full Text] [Related]
9. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
Lambert AL; Mangum JB; DeLorme MP; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):339-46. PubMed ID: 12655033
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice.
de Vrankrijker AM; Wolfs TF; Ciofu O; Høiby N; van der Ent CK; Poulsen SS; Johansen HK
J Med Virol; 2009 Dec; 81(12):2096-103. PubMed ID: 19856469
[TBL] [Abstract][Full Text] [Related]
11. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
13. [Primary respiratory syncytial virus infection in mice].
Zou Y; Huang H; Xu J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
Colasurdo GN; Fullmer JJ; Elidemir O; Atkins C; Khan AM; Stark JM
J Med Virol; 2006 May; 78(5):651-8. PubMed ID: 16555274
[TBL] [Abstract][Full Text] [Related]
15. Effects of tetrabromobisphenol A, a brominated flame retardant, on the immune response to respiratory syncytial virus infection in mice.
Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Hirose A; Kurokawa M
Int Immunopharmacol; 2010 Apr; 10(4):393-7. PubMed ID: 20074668
[TBL] [Abstract][Full Text] [Related]
16. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.
Lupfer C; Patton KM; Pastey MK
Toxicology; 2010 Jan; 268(1-2):25-30. PubMed ID: 19931343
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
Miller AL; Bowlin TL; Lukacs NW
J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
[TBL] [Abstract][Full Text] [Related]
19. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.
Ottolini MG; Curtis SR; Mathews A; Ottolini SR; Prince GA
Bone Marrow Transplant; 2002 Jan; 29(2):117-20. PubMed ID: 11850705
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
Virol J; 2005 May; 2():46. PubMed ID: 15916706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]